extra cellular matrix Search Results


90
Celprogen Inc extracellular matrix pre coated t75 flasks
Extracellular Matrix Pre Coated T75 Flasks, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Human+Adult+Cardiac+Stem+Cell+Culture+Extra-cellular+Expansion+Matrix/us11331348-440-29-35
Average 90 stars, based on 1 article reviews
extracellular matrix pre coated t75 flasks - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
StemBioSys cellvotm chondromatrix coated plasticware
Cellvotm Chondromatrix Coated Plasticware, supplied by StemBioSys, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/CELLvo+ChondroMatrix/pm41935834-364-6-10
Average 99 stars, based on 1 article reviews
cellvotm chondromatrix coated plasticware - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
Celprogen Inc cell culture human bone marrow
Cell Culture Human Bone Marrow, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Human+Bone+Marrow+Derived+Stem+Cell+Culture+Extra-cellular+Expansion+Matrix/pmc06071845-49-0-9
Average 90 stars, based on 1 article reviews
cell culture human bone marrow - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
StemBioSys human ecm coated cell culture plates
Human Ecm Coated Cell Culture Plates, supplied by StemBioSys, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/CELLvo+Matrix+Plus/pmc10320609-219-0-7
Average 93 stars, based on 1 article reviews
human ecm coated cell culture plates - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Celprogen Inc extra cellular matrix
Extra Cellular Matrix, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Human+Pancreatic+Normal+Primary+Cell+Culture+Extra-cellular+Matrix/10__1016_slash_j__rbmo__2025__104895-46-19-21
Average 93 stars, based on 1 article reviews
extra cellular matrix - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Celprogen Inc extracellular matrix
Extracellular Matrix, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Human+Glomerular+Endothelial+Primary+Cell+Culture+Extra-cellular+Expansion+Matrix/pm35472001-242-37-39
Average 90 stars, based on 1 article reviews
extracellular matrix - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

92
Celprogen Inc mesenchymal bone marrow stem cell culture extracellular expansion matrix pre coated t75 flasks
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived <t>extracellular</t> vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Mesenchymal Bone Marrow Stem Cell Culture Extracellular Expansion Matrix Pre Coated T75 Flasks, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Human+Mesenchymal+Bone+Marrow+Stem+Cell+Culture+Extra-cellular+Expansion+Matrix/pmc11493303-129-24-36
Average 92 stars, based on 1 article reviews
mesenchymal bone marrow stem cell culture extracellular expansion matrix pre coated t75 flasks - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
Celprogen Inc human amniotic stem cell
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived <t>extracellular</t> vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Human Amniotic Stem Cell, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Human+Amniotic+Fluid%2F+Membrane+Stem+Cell+Culture+Extra-cellular+Differentiation+Matrix/pmc03183010__supp_22__19__3555_2006_ASCB_Abstracts-14377-13-12
Average 90 stars, based on 1 article reviews
human amniotic stem cell - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Celprogen Inc well plates
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived <t>extracellular</t> vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Well Plates, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Human+Oligodendrocyte+Primary+Cell+Culture+Extra-cellular+Matrix/pm40095747-78-14-20
Average 93 stars, based on 1 article reviews
well plates - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Celprogen Inc 25cm2 tflasks
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived <t>extracellular</t> vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
25cm2 Tflasks, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Mouse+Hypopharyngeal+Primary+Cell+Culture+Extra-cellular+Matrix+Flasks/pmc04868729__oncotarget___07___5892___s001-16-31-41
Average 90 stars, based on 1 article reviews
25cm2 tflasks - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Celprogen Inc lung cancer stem cell culture
(a–c) Characterization and quantification of human-bone marrow <t>mesenchymal</t> stem cell (hBM-MSC)-derived <t>extracellular</t> vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).
Lung Cancer Stem Cell Culture, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extra+cellular+matrix/Human+Lung+Cancer+Stem+Cell+Culture+Extra-cellular+Differentiation+Matrix/pm31938059-57-0-23
Average 90 stars, based on 1 article reviews
lung cancer stem cell culture - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


(a–c) Characterization and quantification of human-bone marrow mesenchymal stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).

Journal: PLOS ONE

Article Title: Recovery after human bone marrow mesenchymal stem cells (hBM-MSCs)-derived extracellular vesicles (EVs) treatment in post-MCAO rats requires repeated handling

doi: 10.1371/journal.pone.0312298

Figure Lengend Snippet: (a–c) Characterization and quantification of human-bone marrow mesenchymal stem cell (hBM-MSC)-derived extracellular vesicles (EVs). (a) Nanosight Tracking analyses (NTA) showing the size distribution pattern of EVs. (b) Western blots of hBM-MSCs marker (GM130) and EVs markers (ALIX, CD9, CD81). “Wash” lane represents the negative control. Each image comes from different blots. (c) Representative image of EVs using transmission electron microscopy (TEM). Scale bar 100 nm. (d–f) In vivo tracking of ExoGlow-labeled EVs demonstrated that EVs reach the brain and accumulate near the stroke injury 6 hours after administration at 2 dps. (d) Timeline of intranasal single dose treatment of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl), starting 2 dps and collecting the tissue 6 hours after. (e) Representative coronal section after a single intranasal administration of ExoGlow-labeled EVs (~2.4 x 10 9 EVs in 200 μl) at 2 dps. Hoechst indicates cell nuclei. Scale bars 4 mm and 100 μm. (f) Quantification of the average size of ExoGlow+ particles in the ipsilateral and contralateral hemispheres. Data was analyzed using a paired t-test (*p<0.05). Bars show mean +/− SD. Each symbol represents the average size of ExoGlow+ particles from all ROIs in each hemisphere (5 ROIs/hemisphere in each rat) of a single rat ( n = 4 ).

Article Snippet: Human bone marrow mesenchymal stem cells (hBM-MSCs) were purchased from Celprogren (frozen vial with ~1.2 x 10 6 cells; #36094–22) and plated on human mesenchymal bone marrow stem cell culture extracellular expansion matrix pre-coated T75 Flasks (Celprogen, #E36094-21-T75) following Celprogren recommendations.

Techniques: Derivative Assay, Western Blot, Marker, Negative Control, Transmission Assay, Electron Microscopy, In Vivo, Labeling